FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vivianne Tjan-Heijnen

Research Profile

Disorders

Procedures

Chemicals & Drugs

Granulocyte Colony-Stimulating Factor

Concepts & Ideas

Anatomy

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Birgit E P J Vriens; Joep P J de Hoon; Dorien J A Lobbezoo; Jürgen Veeck; Adri C Voogd; Vivianne C G Tjan-Heijnen
If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an example.
Sandra M E Geurts; Sabine Siesling; Katja K H Aben; Femmie de Vegt; Karin Flobbe; Margriet van der Heiden-van der Loo; J A A M van Dijck; André L M Verbeek; Vivianne C G Tjan-Heijnen
Pattern of follow-up care and early relapse detection in breast cancer patients.
Sandra M E Geurts; Leon F A G Massuger; Vivianne C G Tjan-Heijnen; Anne M van Altena; Jos A A M van Dijck; Eddy M Adang; Femmie de Vegt; André L M Verbeek
Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vivianne Tjan-Heijnen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Birgit E P J Vriens; Joep P J de Hoon; Dorien J A Lobbezoo; Jürgen Veeck; Adri C Voogd; Vivianne C G Tjan-Heijnen
If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an example.
Cancer treatment reviews 2013;39(2):189-98.
2012: Sandra M E Geurts; Sabine Siesling; Katja K H Aben; Femmie de Vegt; Karin Flobbe; Margriet van der Heiden-van der Loo; J A A M van Dijck; André L M Verbeek; Vivianne C G Tjan-Heijnen
Pattern of follow-up care and early relapse detection in breast cancer patients.
Breast cancer research and treatment 2012;136(3):859-68.
2012: Sandra M E Geurts; Leon F A G Massuger; Vivianne C G Tjan-Heijnen; Anne M van Altena; Jos A A M van Dijck; Eddy M Adang; Femmie de Vegt; André L M Verbeek
Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(7):1150-7.
2012: Annemiek B G Kwast; Marian B E Menke-Pluymers; Vivianne C G Tjan-Heijnen; M J C van der Sangen; Adri C Voogd; Ilse Grandjean; Karin C G M Groothuis-Oudshoorn; Vincent K Y Ho; Lambertus A Kiemeney; Sabine Siesling
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences.
Breast cancer research and treatment 2012;135(1):271-80.
2012: Joep P J de Hoon; Manon van Engeland; Jürgen Veeck; Birgit E P J Vriens; Tim G A Calon; Vivianne C G Tjan-Heijnen
Taxane resistance in breast cancer: a closed HER2 circuit?
Biochimica et biophysica acta 2012;1825(2):197-206.
2012: C J Wink; K Woensdregt; S Hutschemaekers; G A P Nieuwenhuijzen; Jan A Roukema; Vivianne C G Tjan-Heijnen; M J C van der Sangen; Adri C Voogd
Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.
Annals of surgical oncology 2012;19(4):1185-91.
2011: Marie-Christine W Gast; Connie R Jimenez; Jaco C Knol; Jan H M Schellens; Paul N Span; Vivianne C G Tjan-Heijnen; Harm van Tinteren; Marc Zapatka; Marijke Bontenbal; Jos H Beijnen
Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.
Journal of cancer research and clinical oncology 2011;137(12):1773-83.
2011: Janneke P C Grutters; Shanly C Seferina; Vivianne C G Tjan-Heijnen; Roel J W van Kampen; Wim G Goettsch; Manuela A Joore
Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(5):777-84.
2011: Sandra M E Geurts; Femmie de Vegt; Vivianne C G Tjan-Heijnen; Anne M van Altena; Jos A A M van Dijck; André L M Verbeek; L F A G Massuger
Considering early detection of relapsed ovarian cancer: a review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(5):837-45.
2011: RI Lalisang; O J L Loosveld; J W R Nortier; C J Rodenburg; Peter Slee; A E M Smals; Vivianne C G Tjan-Heijnen; Aart van Bochove; E E Voest; Jacob Wals; J A Wils; G H Blijham; F L G Erdkamp; C T A M Knibbeler-van Rossum; H C Schouten
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Breast cancer research and treatment 2011;128(2):437-45.
2011: J Ruiterkamp; Vivianne C G Tjan-Heijnen; Lonneke V van de Poll-Franse; M van der Heiden-van der Loo; E Bastiaannet; Koop Bosscha; L de Munck; Miranda F Ernst; Adri C Voogd
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands.
Breast cancer research and treatment 2011;128(2):495-503.
2011: Sandra M E Geurts; Anne M van Altena; Femmie de Vegt; Vivianne C G Tjan-Heijnen; L F A G Massuger; Jos A A M van Dijck; André L M Verbeek
No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(4):647-53.
2011: M J C van der Sangen; Fenneke M M van de Wiel; Philip M P Poortmans; Vivianne C G Tjan-Heijnen; Grard A P Nieuwenhuijzen; R M H Roumen; Miranda F Ernst; M Cathelijne B J E Tutein Nolthenius-Puylaert; Adri C Voogd
Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.
Breast cancer research and treatment 2011;127(1):207-15.
2011: Tim C de Ruijter; Jürgen Veeck; Joep P J de Hoon; Manon van Engeland; Vivianne C G Tjan-Heijnen
Characteristics of triple-negative breast cancer.
Journal of cancer research and clinical oncology 2011;137(2):183-92.
2011: Matti S Aapro; J Bohlius; D A Cameron; Lissandra Dal Lago; J Peter Donnelly; N Kearney; G H Lyman; Ruth Pettengell; Vivianne C G Tjan-Heijnen; Jan Walewski; Damien C Weber; C Zielinski
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
European journal of cancer (Oxford, England : 1990) 2011;47(1):8-32.
2011: Manon J Pepels; Johanna H M J Vestjens; Maaike de Boer; Marjolein Smidt; Paulus van Diest; George F Borm; Vivianne C G Tjan-Heijnen
Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review.
Breast cancer research and treatment 2011;125(2):301-13.
2010: Ad F Verhagen; Johan Bulten; Hebste Shirango; Frederik B J M Thunnissen; Miep A van der Drift; Wouter van der Bruggen; Vivianne C G Tjan-Heijnen; Henry A van Swieten
The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(8):1201-5.
2010: Yvette W J Paulis; Patricia M M B Soetekouw; Hendrik Verheul; Vivianne C G Tjan-Heijnen; Arjan W Griffioen
Signalling pathways in vasculogenic mimicry.
Biochimica et biophysica acta 2010;1806(1):18-28.
2010: Peter Bult; Peggy Manders; huub straatman; Vivianne C G Tjan-Heijnen; Louk V A M Beex; J Hendriks; Jan Willem Leer; A L M Verbeek; Roland Holland
In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
Breast cancer research and treatment 2010;122(1):77-86.
2010: Brigitte A B Essers; Shanley C Seferina; Vivianne C G Tjan-Heijnen; Johan L Severens; Annoesjka Novák; Marjolein Pompen; Ulrich H Oron; Manuela A Joore
Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(4):375-80.
2010: Paulus van Diest; Maaike de Boer; Carolien van Deurzen; Vivianne C G Tjan-Heijnen
Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):e140; author reply e141-2.
2010: Jetske Ruiterkamp; Adri C Voogd; Koop Bosscha; Vivianne C G Tjan-Heijnen; Miranda F Ernst
Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature.
Breast cancer research and treatment 2010;120(1):9-16.
2010: Vivianne C G Tjan-Heijnen; Manon J Pepels; Maaike de Boer
Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients.
Breast disease 2010;31(2):107-13.
2010: Vivianne C G Tjan-Heijnen
The breast cancer sentinel node dilemma: what to do with isolated tumor cells and micrometastases?
Breast disease 2010;31(2):61-3.
2009: Marieke J Bolster; Peter Bult; Carla A P Wauters; Luc J A Strobbe; Petronella G M Peer; Theo Wobbes; Vivianne C G Tjan-Heijnen
More tumor-affected lymph nodes because of the sentinel lymph node procedure but no stage migration, because the 2002 TNM classifies small tumor deposits as pathologic N0 breast cancer.
Cancer 2009;115(23):5589-95.
2009: Carolien van Deurzen; Birgit E P J Vriens; Vivianne C G Tjan-Heijnen; ELSKEN VAN DER WALL; Mirjam Albregts; Richard van Hilligersberg; Evelyn M Monninkhof; Paulus van Diest
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3124-30.
2009: Maaike de Boer; Carolien van Deurzen; Jos A A M van Dijck; George F Borm; Paulus van Diest; Eddy M M Adang; Johan W R Nortier; Emiel J T Rutgers; Caroline Seynaeve; Marian B E Menke-Pluymers; Peter Bult; Vivianne C G Tjan-Heijnen
Micrometastases or isolated tumor cells and the outcome of breast cancer.
The New England journal of medicine 2009;361(7):653-63.
2009: Vivianne C G Tjan-Heijnen; Carla Boetes
[NHG-standard 'Diagnosis of mammary carcinoma'. Some differences with the multidisciplinary guideline].
Nederlands tijdschrift voor geneeskunde 2009;153(13):586-7.
2009: Carolien van Deurzen; Peter Bult; Maaike de Boer; Ron Koelemij; Richard van Hillegersberg; Vivianne C G Tjan-Heijnen; Monique G G Hobbelink; Peter C de Bruin; Paulus van Diest
Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement?
The American journal of surgical pathology 2009;33(1):106-10.
2008: Carolien van Deurzen; Maaike de Boer; Evelyn M Monninkhof; Peter Bult; ELSKEN VAN DER WALL; Vivianne C G Tjan-Heijnen; Paulus van Diest
Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.
Journal of the National Cancer Institute 2008;100(22):1574-80.
2008: J N H Timmer-Bonte; Cornelis J A Punt; H F M vd Heijden; CE van Die; Johan Bussink; J H Beijnen; Alwin D R Huitema; Vivianne C G Tjan-Heijnen
Prophylactic G-CSF and antibiotics enable a significant dose-escalation of triplet-chemotherapy in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):222-30.
2008: Vincent K Y Ho; Margriet van der Heiden-van der Loo; Emiel J Th Rutgers; Paulus van Diest; Monique G G Hobbelink; Vivianne C G Tjan-Heijnen; Miranda J M Dirx; Ardine M J Reedijk; Jos A A M van Dijck; Lonneke V van de Poll-Franse; Michael Schaapveld; Petra Peeters
Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
European journal of cancer (Oxford, England : 1990) 2008;44(5):683-91.
2008: Johanna N H Timmer-Bonte; Eddy M M Adang; Evelien Termeer; Johan L Severens; Vivianne C G Tjan-Heijnen
Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):290-6.
2008: Marie-Christine W Gast; Harm van Tinteren; Marijke Bontenbal; René Q G C M van Hoesel; Marianne A Nooij; Sjoerd Rodenhuis; Paul N Span; Vivianne C G Tjan-Heijnen; Elisabeth G E de Vries; Nathan Harris; Jos W R Twisk; Jan H M Schellens; Jos H Beijnen
Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.
BMC cancer 2008;8():389.
2007: Mariëlle M M T J Ouwens; Rosella R P M G Hermens; René A R Termeer; Saskia Y Vonk-Okhuijsen; Vivianne C G Tjan-Heijnen; Ad F T M Verhagen; Marlies M E J L Hulscher; Henri Marres; Hub Wollersheim; Richard P T M Grol
Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
Cancer 2007;110(8):1782-90.
2007: Paul Span; Vivianne C G Tjan-Heijnen; Fred C G J Sweep
Is survivin expression nevertheless related to disease outcome in breast cancer?
Breast cancer research and treatment 2007;103(1):109.
2007: P M M B Soetekouw; Robert T M van Dongen; R Maas; Peter Bult; Carla Boetes; Vivianne C G Tjan-Heijnen
[Palliation in patients with metastatic breast cancer often better with antitumour treatment than with only symptomatic treatment].
Nederlands tijdschrift voor geneeskunde 2007;151(12):673-8.
2007: Jan P van Meerbeeck; Gijsbert W P M Kramer; Paul E Y Van Schil; Catherine Legrand; Egbert F Smit; Franz Schramel; Vivianne C G Tjan-Heijnen; Bonne Biesma; Channa Debruyne; nico van zandwijk; Ted A W Splinter; Giuseppe Giaccone
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
Journal of the National Cancer Institute 2007;99(6):442-50.
2007: Marieke J Bolster; Petronella G M Peer; Peter Bult; Frederik B J M Thunnissen; René F M Schapers; Jos W R Meijer; Luc J A Strobbe; C L H van Berlo; J H G Klinkenbijl; Louk V A M Beex; Theo Wobbes; Vivianne C G Tjan-Heijnen
Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study.
Annals of surgical oncology 2007;14(1):181-9.
2006: Marieke J Bolster; Peter Bult; René F M Schapers; Jos W R Meijer; Luc J A Strobbe; C L H van Berlo; J H G Klinkenbijl; Petronella G M Peer; Theo Wobbes; Vivianne C G Tjan-Heijnen
Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients.
Annals of surgical oncology 2006;13(11):1466-73.
2006: Rosella P M G Hermens; Mariëlle M M T J Ouwens; S Y Vonk-Okhuijsen; Y van der Wel; Vivianne C G Tjan-Heijnen; L D van den Broek; V K Y Ho; M L G Janssen-Heijnen; H J M Groen; Richard P T M Grol; Hub Wollersheim
Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
Lung cancer (Amsterdam, Netherlands) 2006;54(1):117-24.
2006: Matti S Aapro; D A Cameron; Ruth Pettengell; J Bohlius; Jeffrey Crawford; M Ellis; N Kearney; G H Lyman; Vivianne C G Tjan-Heijnen; Jan Walewski; D C Weber; C Zielinski
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.
European journal of cancer (Oxford, England : 1990) 2006;42(15):2433-53.
2006: Johanna N H Timmer-Bonte; Vivianne C G Tjan-Heijnen
Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
Anti-cancer drugs 2006;17(8):881-9.
2006: Paul Span; Vivianne C G Tjan-Heijnen; Joop J T M Heuvel; Jacques B de Kok; John A Foekens; Fred C G J Sweep
Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
Clinical chemistry 2006;52(9):1693-700.
2006: Peter Bult; Vivianne C G Tjan-Heijnen; H van Krieken
[Effects and costs of adjuvant chemotherapy for operable lymph node positive breast cancer with HER2/neu overexpression].
Nederlands tijdschrift voor geneeskunde 2006;150(26):1481; author reply 1481-3.
2006: Gijsbert W P M Kramer; Catherine L Legrand; Paul Van Schil; Lon Uitterhoeve; Egbert F Smit; Franz Schramel; Bonne Biesma; Vivianne C G Tjan-Heijnen; nico van zandwijk; Ted A W Splinter; Giuseppe Giaccone; Jan P van Meerbeeck
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1391-8.
2006: Johanna N H Timmer-Bonte; Eddy M M Adang; Hans J M Smit; Bonne Biesma; Frank A Wilschut; Gerben P Bootsma; Theo M de Boo; Vivianne C G Tjan-Heijnen
Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):2991-7.
2006: Paul Span; Vivianne C G Tjan-Heijnen; Peggy Manders; Doorléne T H van Tienoven; jeffrey lehr; Fred C G J Sweep
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer.
Breast cancer research and treatment 2006;98(2):223-30.
2006: Leon Holzscheiter; Julia C Biermann; Matthias Kotzsch; Panagiotis Prezas; Juliane Farthmann; Gustavo B Baretton; Thomas Luther; Vivianne C G Tjan-Heijnen; Maroulio Talieri; Manfred Schmitt; Fred C G J Sweep; Paul Span; Viktor Magdolen
Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer.
Clinical chemistry 2006;52(6):1070-9.
2006: John A Foekens; David Atkins; Yi Zhang; Fred C G J Sweep; Nadia Harbeck; angelo paradiso; Tanja Cufer; Anieta M Sieuwerts; Dmitri Talantov; Paul Span; Vivianne C G Tjan-Heijnen; Alfredo F Zito; Katja Specht; Heinz Hoefler; Rastko Golouh; Francesco Schittulli; Manfred Schmitt; Louk V A M Beex; Jan G M Klijn; Yixin Wang
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(11):1665-71.
2006: Sarah Porter; Paul Span; Fred C G J Sweep; Vivianne C G Tjan-Heijnen; Caroline J Pennington; Tanja Xenia Pedersen; Morten Johnsen; Leif R Lund; John Rømer; Dylan R Edwards
ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma.
International journal of cancer. Journal international du cancer 2006;118(5):1241-7.
2005: W Kievit; Marieke J Bolster; Gert Jan van der Wilt; Peter Bult; Frederik B J M Thunnissen; J Meijer; Luc J A Strobbe; J H G Klinkenbijl; Theo Wobbes; Eddy M M Adang; Louk V A M Beex; Vivianne C G Tjan-Heijnen
Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(12):1874-81.
2005: Johanna N H Timmer-Bonte; Theo M de Boo; Hans J M Smit; Bonne Biesma; Frank A Wilschut; Samia A Cheragwandi; Arien Termeer; Cornelis A Hensing; Janine Akkermans; Eddy M M Adang; Gerben P Bootsma; Vivianne C G Tjan-Heijnen
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7974-84.
2005: Matthias Kotzsch; Juliane Farthmann; Axel Meye; Susanne Fuessel; Gustavo B Baretton; Vivianne C G Tjan-Heijnen; Manfred Schmitt; Thomas Luther; Fred C G J Sweep; Viktor Magdolen; Paul Span
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(17):2760-8.
2005: Johanna N H Timmer-Bonte; P H M De Mulder; Petronella G M Peer; Louk V A M Beex; Vivianne C G Tjan-Heijnen
Timely withdrawal of G-CSF reduces the occurrence of thrombocytopenia during dose-dense chemotherapy.
Breast cancer research and treatment 2005;93(2):117-23.
2005: Vivianne C G Tjan-Heijnen; Peter Bult; Marieke J Bolster; Petronella G M Peer; Theo Wobbes
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
Nederlands tijdschrift voor geneeskunde 2005;149(9):494; author reply 494-5.
2005: Jan P van Meerbeeck; C C E Koning; Vivianne C G Tjan-Heijnen; A G Boekema; C J E Kaandorp; J S Burgers
[Guideline on 'non-small cell lung carcinoma; staging and treatment'].
Nederlands tijdschrift voor geneeskunde 2005;149(2):72-7.
2004: Paul Span; Fred C G J Sweep; Erwin T G Wiegerinck; Vivianne C G Tjan-Heijnen; Peggy Manders; Louk V A M Beex; Jacques B de Kok
Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
Clinical chemistry 2004;50(11):1986-93.
2004: Peggy Manders; Vivianne C G Tjan-Heijnen; Paul Span; Nicolai Grebenchtchikov; Anneke Geurts-Moespot; Doorléne T H van Tienoven; Louk V A M Beex; Fred C G J Sweep
Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
Cancer 2004;101(3):486-94.
2004: Peggy Manders; Louk V A M Beex; Vivianne C G Tjan-Heijnen; Paul Span; C G J Sweep
Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients.
International journal of oncology 2004;25(2):511-7.
2004: Ad F T M Verhagen; E Bollen; Vivianne C G Tjan-Heijnen; Gerben P Bootsma; A Hensens; Wim J G Oyen
[The biopsying of at least 5 mediastinal lymph node stations for presurgical staging in patients with a non-small-cell lung carcinoma].
Nederlands tijdschrift voor geneeskunde 2004;148(18):908; author reply 908-9.
2004: Ad F T M Verhagen; Gerben P Bootsma; Vivianne C G Tjan-Heijnen; Gert Jan van der Wilt; A L Cox; M H J Brouwer; Frans H M Corstens; Wim J G Oyen
FDG-PET in staging lung cancer: how does it change the algorithm?
Lung cancer (Amsterdam, Netherlands) 2004;44(2):175-81.
2004: Paul Span; Raija L P Lindberg; Peggy Manders; Vivianne C G Tjan-Heijnen; Joop J T M Heuvel; Louk V A M Beex; C G J Sweep
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.
The Journal of pathology 2004;202(4):395-402.
2004: Peggy Manders; Vivianne C G Tjan-Heijnen; Paul Span; Nicolai Grebenchtchikov; Anneke Geurts-Moespot; Doorléne T H van Tienoven; Louk V A M Beex; Fred C G J Sweep
The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.
Thrombosis and haemostasis 2004;91(3):514-21.
2004: Peggy Manders; Vivianne C G Tjan-Heijnen; Paul Span; Nicolai Grebenchtchikov; John A Foekens; Louk V A M Beex; C G J Sweep
Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer.
Cancer research 2004;64(2):659-64.
2003: Peggy Manders; Fred C G J Sweep; Vivianne C G Tjan-Heijnen; Anneke Geurts-Moespot; Doorléne T H van Tienoven; John A Foekens; Paul Span; Johan Bussink; Louk V A M Beex
Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6363-70.
2003: Peggy Manders; Louk V A M Beex; Vivianne C G Tjan-Heijnen; Paul Span; C G J Sweep
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.
Cancer 2003;98(10):2125-32.
2003: Lazzaro Repetto; L Biganzoli; C H Koehne; A S Luebbe; Pierre Soubeyran; Vivianne C G Tjan-Heijnen; Matti S Aapro
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(16):2264-72.
2003: Paul Span; Vivianne C G Tjan-Heijnen; Peggy Manders; Louk V A M Beex; C G J Sweep
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.
Oncogene 2003;22(31):4898-904.
2003: M E R O'Brien; Ted A W Splinter; Egbert F Smit; Bonne Biesma; Maciej Krzakowski; Vivianne C G Tjan-Heijnen; Aart van Bochove; J Stigt; M J A Smid-Geirnaerdt; Channa Debruyne; Catherine Legrand; Giuseppe Giaccone
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).
European journal of cancer (Oxford, England : 1990) 2003;39(10):1416-22.
2003: Louise de Widt-Levert; Vivianne C G Tjan-Heijnen; Peter Bult; T J M Ruers; Theo Wobbes
Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(3):216-20.
2003: Vivianne C G Tjan-Heijnen; S Caleo; Pieter E Postmus; Andrea Ardizzoni; Jos Burghouts; E Buccholz; Bonne Biesma; Thierry Gorlia; R Crott; Giuseppe Giaccone; Channa Debruyne; Christian Manegold
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):248-57.
2003: Peggy Manders; Peter Bult; C G J Sweep; Vivianne C G Tjan-Heijnen; Louk V A M Beex
The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy.
Breast cancer research and treatment 2003;77(1):77-84.
2002: Vivianne C G Tjan-Heijnen; D J Th Wagener; Pieter E Postmus
An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1519-30.
2002: Andrea Ardizzoni; Vivianne C G Tjan-Heijnen; Pieter E Postmus; Erika Buchholz; Bonne Biesma; Hanna Karnicka-Mlodkowska; Rafal Dziadziuszko; Jos Burghouts; Jan P van Meerbeeck; Steven Gans; Catherine Legrand; Channa Debruyne; Giuseppe Giaccone; Christian Manegold
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):3947-55.
2002: Peggy Manders; Louk V A M Beex; Vivianne C G Tjan-Heijnen; J Geurts-Moespot; TH van Tienoven; John A Foekens; C G J Sweep
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
British journal of cancer 2002;87(7):772-8.
2002: Vivianne C G Tjan-Heijnen; P E Postmus; Andrea Ardizzoni
Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'", by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339-1340).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):485-6; author reply 486-7.
2001: Vivianne C G Tjan-Heijnen; P Buit; L M de Widt-Evert; T J Ruers; Louk V A M Beex
Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure.
Breast cancer research and treatment 2001;70(2):81-8.
2001: Vivianne C G Tjan-Heijnen; Pieter E Postmus; Andrea Ardizzoni; Christian Manegold; Jos Burghouts; Jan P van Meerbeeck; Steven Gans; M Mollers; Erika Buchholz; Bonne Biesma; Catherine Legrand; Channa Debruyne; Giuseppe Giaccone
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(10):1359-68.
2001: J A A M van Dijck; Joost M Festen; E M H A de Kleijn; Gijsbert W P M Kramer; Vivianne C G Tjan-Heijnen; André L M Verbeek
Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):19-27.
1999: Louk V A M Beex; Vivianne C G Tjan-Heijnen; PB Ottevanger
[Chemotherapy in metastasized breast cancer].
Nederlands tijdschrift voor geneeskunde 1999;143(1):59-60.
1998: Vivianne C G Tjan-Heijnen; Bonne Biesma; Joost M Festen; Ted A W Splinter; A Cox; D J Th Wagener; Pieter E Postmus
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2708-14.
1998: Vivianne C G Tjan-Heijnen; L Th Vlasveld; F P Pernet; P Pauwels; P H M De Mulder
Coincidence of seminoma and sarcoidosis: a myth or fact?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):321-5.
1997: Vivianne C G Tjan-Heijnen; P E Postmus; D J Th Wagener
Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer.
Anti-cancer drugs 1997;8(6):549-64.